Enzo Biochem Inc.

Enzo Biochem Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
47.17 M
Public Float
44.43 M
Enzo Biochem Inc.
Stock Exchange New York Stock Exchange
EPS
$0.04
Market Cap
$173.58 M
Shares Outstanding
47.56 M
Public Float
43.75 M

Profile

Address
60 Executive Boulevard
New York New York 11735
United States
Employees -
Website http://www.enzo.com
Updated 07/08/2019
Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W.

Financials

View All

Elazar Rabbani
Chairman, Chief Executive Officer & Secretary
Barry W. Weiner
President, CFO, Treasurer & Director